Live News Categoriesmarket

CELC.O (CELC.O) News

Track canonical SquawkNews coverage tagged to CELC.O, CELC.O. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol CELC.O Asset market Sector Markets 90 days 1 Updated Sep 30, 2026, 01:20 PM UTC Open live news feed

M Celcuity shares rise on US launch of breast cancer drug Revtorpyk Shares of drugmaker Celcuity rose 4.11% to $80.56 premarket after the company announced its FDA-approved breast cancer drug Revtorpyk is now commercially available in the US. The drug is approved with fulvestrant for cer EQUITY | Sep 30, 2026, 01:20 PM UTC